Articulatory Adaptation Following Oral Cancer Treatment

NCT ID: NCT05876247

Last Updated: 2023-05-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-10

Study Completion Date

2025-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this longitudinal study is to learn more about the articulatory consequences of surgical oral cancer treatment. The main aims are to study the coordination and development of speech articulation of patients who will undergo surgical treatment for oral cancer longitudinally and whether individual differences in the reliance on auditory or tactile information can predict the success of speech compensatory strategies.

Participants will perform multiple speech tasks while motion tracking sensors track the articulatory gestures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Cavity Squamous Cell Carcinoma Speech Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Individuals treated for oral cancer

Dutch native speakers (18+) who will undergo surgical treatment for a T1 or T2 tumour on the tongue.

Electromagnetic Articulography

Intervention Type OTHER

Motion tracking sensors will track articulatory movements of the tongue, jaw and lips

Control speakers

Dutch native speakers (18+) without self-reported speech problems.

Electromagnetic Articulography

Intervention Type OTHER

Motion tracking sensors will track articulatory movements of the tongue, jaw and lips

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electromagnetic Articulography

Motion tracking sensors will track articulatory movements of the tongue, jaw and lips

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Diagnosed with T1 or T2 tumor in the oral cavity
2. At least 18 years old and able to provide informed consent
3. Native speaker of Dutch
4. Has nog been treated for oral cancer before

Exclusion Criteria

1a. Recurrence of disease (for patients)

1b. Treated for oral cancer (for healthy controls) 2. Speech problems (e.g., stuttering) 3. Problems with sight or hearing that impede reading or understanding instructions. When glasses or a hearing aid resolve these problems, then participants are not excluded.

4\. Neurological or psychological disorders (e.g., stroke) 5. Non-removable metal in, on or around the head (piercings, braces, pacemaker, electrodes) 6. Self-reported signs of depression
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Medical Center Groningen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Max Witjes, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Groningen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Arts, University of Groningen

Groningen, , Netherlands

Site Status RECRUITING

University Medical Centre Groningen

Groningen, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thomas Tienkamp, MA

Role: CONTACT

+31 50 36 37051

Max Witjes, PhD

Role: CONTACT

+31 (0)50 361 3841

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thomas Tienkamp, MA

Role: primary

+31 50 36 37051

Thomas Tienkamp, MA

Role: primary

+31 50 36 37051

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

METc 2021/711

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.